Physician profile
Ozgur Dede
NPI 1881998375
$4,181.71
in general payments reported to CMS, 2019-2025
9 companies · $1,673 in 2025
The $1,673 reported for 2025 was more than what 79% of Pediatric Orthopaedic Surgery providers received nationally (typical 2025 total: $271).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $177 · 2020: $719 · 2022: $1,201 · 2023: $392 · 2024: $19.35 · 2025: $1,673.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,411 · Food and Beverage: $673.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,411.15 |
| Food and Beverage | $673.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthopediatrics Corp. | $1,673.01 | 2025 | |
| Zimmer Biomet Holdings, INC. | $1,160.14 | 2019-2022 | |
| Zimvie INC. | $804.59 | 2022 | |
| Medical Device Business Services, INC. | $227.64 | 2019-2023 | Conduit |
| Stryker Corporation | $153.92 | 2023 | Cranialmask Tracker |
| Depuy Synthes Sales INC. | $93.34 | 2022-2023 | Altalyne |
| Biomarin Pharmaceutical INC. | $38.18 | 2023 | Voxzogo 1.2mg |
| Medtronic, INC. | $19.35 | 2024 | Unid_pass |
| Nuvasive, INC. | $11.54 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ozgur Dede listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.